Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers

Journal of Clinical Epidemiology

Volumn 76, Issue , 2016, Pages 147-154

  Akl, Elie A ^a,b   Kahale, Lara A ^a   Ebrahim, Shanil ^b,c,d,e   Alonso Coello, Pablo ^f   Schünemann, Holger J ^b   Guyatt, Gordon H ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Attrition bias; Lost to follow up; Missing participant data; Non compliance; Randomized controlled trials; Systematic reviews

Indexed keywords

ANTICOAGULATION; ARTICLE; CONSENSUS DEVELOPMENT; FOLLOW UP; HUMAN; META ANALYSIS (TOPIC); MISSING PARTICIPANT DATA; PATIENT INFORMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); LITERATURE; MEDICAL RESEARCH; METHODOLOGY; NEOPLASMS; PROCEDURES; STATISTICS; TREATMENT OUTCOME;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; BIOMEDICAL RESEARCH; HUMANS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84961219303     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.02.022     Document Type: Article

References (21)

1. [1] Akl, E.A., Briel, M., You, J.J., Sun, X., Johnston, B.C., Busse, J.W., et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ, 344, 2012, e2809.
2. [2] Sylvestre, Y., CONSORT: missing missing data guidelines, the effects on HTA monograph reporting. Trials, 12(Suppl 1), 2011, A61.
3. [3] Karlson, C.W., Rapoff, M.A., Attrition in randomized controlled trials for pediatric chronic conditions. J Pediatr Psychol 34:7 (2009), 782–793.
4. [4] Higgins, J.T., Green, S., Cochrane Handbook for Systematic Reviews of Interventions. 2011, John Wiley & Sons, Chichester (UK).
5. [5] Ebrahim, S., Akl, E.A., Mustafa, R.A., Sun, X., Walter, S.D., Heels-Ansdell, D., et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol 66 (2013), 1014–1021.e1.
6. [6] Akl, E.A., Johnston, B.C., Alonso-Coello, P., Neumann, I., Ebrahim, S., Briel, M., et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One, 8, 2013, e57132.
7. [7] Ebrahim, S., Johnston, B.C., Akl, E.A., Mustafa, R.A., Sun, X., Walter, S.D., et al. Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. J Clin Epidemiol 67 (2014), 560–570.
8. [8] Turner, L., Shamseer, L., Altman, D.G., Schulz, K.F., Moher, D., Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev, 1, 2012, 60.
9. [9] Spineli, L.M., Pandis, N., Salanti, G., Reporting and handling missing outcome data in mental health: a systematic review of Cochrane systematic reviews and meta-analyses. Res Synth Methods 6:2 (2015), 175–187.
10. [10] Akl, E.A., Kahale, L.A., Ballout, R.A., Barba, M., Yosuico, V.E., van Doormaal, F.F., et al. Parenteral anticoagulation in ambulatory patients with cancer. Cochrane Database Syst Rev, 2014, CD006652.
11. [11] Akl, E.A., Kahale, L., Terrenato, I., Neumann, I., Yosuico, V.E., Barba, M., et al. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev, 2014, CD006466.
12. [12] Akl, E.A., Kahale, L., Sperati, F., Neumann, I., Labedi, N., Terrenato, I., et al. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database Syst Rev, 2014, CD009447.
13. [13] Akl, E.A., Kahale, L., Barba, M., Neumann, I., Labedi, N., Terrenato, I., et al. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev, 2014, CD006650.
14. [14] Akl, E.A., Ramly, E.P., Kahale, L.A., Yosuico, V.E., Barba, M., Sperati, F., et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev, 2014, CD006468.
15. [15] Akl, E.A., Carrasco-Labra, A., Brignardello-Petersen, R., Neumann, I., Johnston, B.C., Sun, X., et al. Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey. BMJ Open, 5(9), 2015, e009368.
16. [16] Akl, E.A., Briel, M., You, J.J., Lamontagne, F., Gangji, A., Cukierman-Yaffe, T., et al. LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials, 10, 2009, 40.
17. [17] Briggs, D.D. Jr., Covelli, H., Lapidus, R., Bhattycharya, S., Kesten, S., Cassino, C., et al. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther 18:6 (2005), 397–404.
18. [18] De Cicco, M., Matovic, M., Balestreri, L., Steffan, A., Pacenzia, R., Malafronte, M., et al. Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies. Ann Oncol 20 (2009), 1936–1942.
19. [19] Mavridis, D., Chaimani, A., Efthimiou, O., Leucht, S., Salanti, G., et al. Addressing missing outcome data in meta-analysis. Evid Based Ment Health 17:3 (2014), 85–89.
20. [20] Doshi, P., Goodman, S.N., Ioannidis, J.P., Raw data from clinical trials: within reach?. Trends Pharmacol Sci 34:12 (2013), 645–647.
21. [21] Taichman, D.B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P.W., Drazen, J.M., et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Dan Med J, 63(2), 2016.